- Efficacy and Safety of Benralizumab for Korean Patients With Severe, Uncontrolled Eosinophilic Asthma
-
Park HS, Lee SH, Lee SY, Kim MK, Lee BJ, Werkström V, Barker P, Zangrilli
- KMID: 2448753
- Allergy Asthma Immunol Res.
- 2019 Jul;11(4):508-518.
- doi: 10.4168/aair.2019.11.4.508
PURPOSE: In the Phase III SIROCCO trial (NCT01928771), benralizumab significantly reduced asthma exacerbations and improved lung function and symptoms for patients with severe, uncontrolled eosinophilic asthma. The aim of this... -
- CITED
-
- Close
- SHARE
-
- Close
